Fluifort Syrup (carbositeine)

Fluifort syrup is used as a mucolytic, fluidifying agent in acute and chronic respiratory diseases.
It is contraindicated in:
• case of hypersensitivity to the active substance or to any of the excipients;
• gastroduodenal ulcer;
• pregnancy and breastfeeding;
• children under 2 years of age.
Patients with rare hereditary problems of glucose intolerance, glucose-galactose malabsorption or sucrose-isomaltase enzyme insufficiency should not take this medicine.
The medicine contains methyl para-hydroxybenzoate, which is known to cause hives.
In general, para-hydroxybenzoates can cause delayed reactions, such as contact dermatitis and rarely immediate reactions with manifestation of urticaria and bronchospasm.
It does not contain gluten;
therefore it can be administered to patients with celiac disease.
It does not contain aspartame;
therefore it can be administered to patients with phenylketonuria.
Pregnancy and breastfeedingAsk your doctor or pharmacist for advice before taking any medicine.
Fluifort should not be administered during pregnancy.
Since no data are available regarding the passage of carbocysteine ​​lysine salt monohydrate into breast milk, use during lactation is contraindicated.
Its use should also be avoided if you suspect a pregnancy or wish to plan a maternity leave.
This is an OTC medicine, so it can be taken without a doctor’s recommendation.
Before using this medicine carefully read the package leaflet as it contains more detailed information.
Consult your doctor or pharmacist for any doubt.